suppress systemic body growth, while high-level ecdysone peaks limit the larval growth period by triggering pupariation.
In addition to nutrients, organisms require oxygen for growth and development. Organisms have therefore developed oxygen-sensing mechanisms that allow them to adapt their metabolism and growth to low oxygen concentrations. In many organisms, hypoxia (low oxygen level) slows growth, leading to delayed development and smaller adults. In Drosophila and other insects, hypoxia restricts growth and whole-body size 4, [20] [21] [22] [23] [24] . Furthermore, in humans, the limited oxygen associated with high-altitude living has been linked to slowed growth and developmental delay 25, 26 .
This effect arises at oxygen concentrations above those that compromise the basic metabolic rate 27, 28 , suggesting that this is not simply an effect of an insufficiency of O2 to support aerobic respiration, but rather an active adaptation under genetic control. The conserved transcription factor Hypoxia-Inducible Factor 1 alpha (HIF-1a) is the key regulator required for adaptive hypoxia responses 29 . At a rate proportional to oxygen levels, the enzyme HIF-1a Prolyl Hydroxylase (Hph)
hydroxylates specific residues in the oxygen-dependent degradation (ODD) domain of HIF-1a, leading to its degradation. Under hypoxic conditions, oxygen is insufficiently available for this process, and HIF-1a becomes stable and dimerizes with the constitutively expressed HIF-1 beta (HIF-1b), translocates to the nucleus, and induces target-gene expression. While it is well established that nutrients mainly affect growth through insulin, the precise mechanism by which limited oxygen restricts systemic growth as an adaptation for survival under low oxygen levels remains to be determined.
To identify signaling mechanisms with roles in regulating systemic growth and body size, we conducted an RNAi-based screen of 1,845 genes encoding potential secreted factors and their receptors. The receptor tyrosine kinase gene breathless (btl) 30, 31 , which encodes an FGF-receptor (FGFR) homolog, was one of the strongest hits. This receptor is expressed by cells of the tracheae, the gas-delivery tubules of the insect respiratory system. Its FGF-like ligand Branchless (Bnl) is produced by target tissues in a stereotyped pattern during development 32 and in response to hypoxia during larval growth 33, 34 to guide the tracheal terminal branches toward target tissues. When this system is perturbed, internal tissues experience hypoxia. We found that tissue hypoxia -actual hypoxia induced by manipulation of Btl-mediated tracheal growth or external O2 levels, or genetically induced fictive hypoxia adaptation via Hph or HIF-1a perturbations -altered the expression of Dilp2, -3, and -5 in the IPCs and blocked DILP release, leading to reduced systemic insulin signaling. We further report that the primary sensor of internal oxygen levels is the fat body, which in response to hypoxia releases one or more as-yet unidentified insulinostatic humoral factors that induces these changes in IPC physiology. Understanding the changes brought about by hypoxia in this model system may allow greater understanding of human disease associated with tissuehypoxia such as obesity and diabetes.
Results

In-vivo RNAi screen identifies signals affecting body size
We undertook a genetic RNAi-knockdown 35, 36 screen targeting 1,845 genes encoding the Drosophila secretome and receptome (Fig. 1A , Supplemental Table 1 ). Ubiquitous gene knockdown using the daughterless-GAL4 driver (da>) identified 89 genes whose manipulation resulted in significantly large or small pupae ( Fig. 1B and 1C ). Among these hits were several genes already known to regulate body or tissue growth ( Fig. 1C and 1D ), including those encoding the insulin receptor (InR) 37 , Anaplastic lymphoma kinase (Alk) 38 and its ligand Jelly Belly (Jeb) 39 , the epidermal growth-factor receptor (EGFR) 40 , and the PTTH receptor Torso 41 , thus validating our approach. Genes important for ecdysone signaling (knirps, Eip75B, Npc2g, and Torso [41] [42] [43] [44] ) were among the hits that increased pupal body size, consistent with the growth-limiting effects of ecdysone. On the other hand, knockdown of the growth-promoting InR produced a strong decrease in body size. Among the strongest hits associated with reduced growth, we also identified FGFpathway signaling (Fig. S1 ). The main hit, the FGFR ortholog breathless (btl), and its FGF-ligand Branchless (Bnl), are critical for proper tracheation of tissues to allow for gas exchange and oxygen delivery 30, 31 .
The FGF receptor Breathless affects systemic growth through effects on tracheae
Ubiquitous btl knockdown (da>btl-RNAi) caused a ~30% reduction in pupal size ( Fig. 2A and 2B ).
Likewise, whole-body knockdown of the ligand bnl strongly reduced growth. Knockdown of the upstream transcription factor trachealess (trh) 45 , which is also required for tracheal formation, reduced body size to a lesser degree, perhaps because of low RNAi efficiency combined with the activity of Trh-independent feedback signaling later in tracheal development 46 . The main btlexpressing tissue is the tracheal system, but the gene is also active in other cell types such as glia 30 .
To identify the tissue causing the size phenotype, we assayed the effect of btl RNAi in the tracheae (btl>btl-RNAi) as well as in the nervous system (elav>), muscles (Mef2>), and fat body (ppl>).
Only tracheal knockdown of btl led to reduced body size (Fig. 2C) ; the specificity of the RNAi Fig. 1 . In-vivo RNAi screen of the secretome and receptome for factors regulating body size. a General scheme of the RNAi screen of 1,845 genes of the Drosophila secretome and receptome selected by gene-ontology analysis. UAS-inducible RNAi constructs against these genes were expressed ubiquitously using da-GAL4 for global knockdown, and pupal size was determined. b-c Distribution of the pupal sizes from the screen revealed (b) 89 gene hits that significantly resulting size increase (c: blue, top) or decrease (c: orange, bottom) body size (a Z-score > ± 2 was used as a cut off) by the comparison to the mean of all lines. d Genes and pathways with known sizeregulatory function identified in the screen, as well as breathless (btl), are marked with arrows.
effect was confirmed with two additional independent RNAi lines against btl that produced similar growth phenotypes (Fig. S2A) . Knockdown of btl in the tracheae delayed pupariation, prolonging the larval growth period, suggesting that the body-size reduction was the result of a reduced growth rate (Fig. S2B) . To investigate this, we determined the growth rate during the third larval instar (L3) and found that loss of btl in the trachea slows the growth of the entire animal (Fig. 2D ). Together these findings show that loss of btl in the tracheal system leads to systemic growth reduction, possibly as a consequence of oxygen restriction.
Fig. 2.
Loss of the FGF receptor breathless in the tracheae reduces growth and body size. a-b Quantification of pupal sizes (a) and representative images (b) of animals with ubiquitous knockdown of breathless (btl)-pathway components compared to the controls (da>+; da> crossed to wild type, w 1118 ). Values are percent change in pupal size versus control. c Knockdown of btl in whole animals (da>btl-RNAi) or tracheae alone (btl>btl-RNAi), but not in neurons (elav>btl-RNAi), muscle (Mef2>btl-RNAi), or fat-body tissue (ppl>btl-RNAi), leads to small animals compared to da>+ controls. Shown also is the RNAi control (btl-RNAi/+; btl-RNAi crossed to wild type, w 1118 ). Values are percent change in pupal size versus the btl>+ controls (btl> crossed to wild type, w 1118 ). d Trachea-specific knockdown of btl reduces larval growth rates compared to driver (btl>+) and RNAi controls (btl-RNAi/+). Statistics: one-way ANOVA with Dunnett's multiple-comparisons test. ***, P<0.001, compared to the control.
The breathless-RNAi size phenotype is mediated by insulin signaling
Among the primary regulators of systemic growth in Drosophila are the DILPs 10, 47 . To assess whether the body-size phenotype of btl knockdown was mediated by alterations in insulin signaling, we first examined the effects of reducing insulin signaling on development and body size. We found that global reduction of insulin signaling by InR knockdown or inhibition of the TOR-dependent fat-body nutrient sensor by tissue-specific expression of the TOR inhibitors TSC1 and TSC2 (TSC1/2), both strongly reduced pupal size (Fig. 3A ) and prolonged development (Fig. S3A) , phenocopying the trachea-specific loss of btl. To identify any alterations in insulin expression caused by btl>btl-RNAi, we determined the level of Dilp2, -3, and -5 gene expression in feeding third-instar larvae, ~24 hours prior to pupariation. Indeed, a very strong reduction (>90%) in Dilp3 expression was observed in RNAi animals, accompanied by a smaller decrease in Dilp5 transcripts (Fig. 3B ).
Since insulin activity is also regulated at the level of DILP release 48 , we investigated whether tracheal btl loss induced IPC retention of DILP2, -3, and -5. Animals with trachea-specific btl knockdown exhibited an accumulation of these DILPs in their IPCs (Fig. 3C) , despite the reduced expression of Dilp3 and Dilp5. This indicates a strong decrease in DILP secretion in larvae with reduced expression of btl in the trachea. Presumably, this retention of insulin would reduce signaling through InR in peripheral tissues. To assess this, we measured downstream insulinsignaling mediators. Insulin signaling leads to the phosphorylation of the kinase Akt (pAkt) and suppression of InR as part of a feedback circuit regulating cellular sensitivity to insulin 49, 50 . We observed InR upregulation and pAkt reduction in btl>btl-RNAi animals ( Fig. 3D, 3E , and 3F), indicating a reduction in systemic insulin signaling, presumably arising from blocked IPC DILP release. To determine whether the observed reduction in insulin signaling was the direct cause of the observed size phenotype, we asked whether rescuing circulating insulin levels by overexpression of Dilp2 would also rescue growth. Ubiquitous expression of Dilp2 using da-GAL4
caused lethality, so we used the weaker ubiquitous armadillo-GAL4 driver (arm>) and found again that btl knockdown led to reduced body size (Fig. 3G) . Overexpression of Dilp2 in this context rescued the size defect (Fig. 3G) , supporting the hypothesis that the size phenotype is caused by a systemic reduction in insulin signaling downstream of Btl.
An alternative explanation for the observed reduced body size involves increased ecdysone signaling, which antagonizes insulin signaling and suppresses larval body growth 17 . However, under btl knockdown we observed reduced expression of the ecdysone-induced gene E75B, which Immunoblotting showing whole-animal levels of phosphorylated Akt (pAkt) kinase (e) in btl>btl-RNAi animals compared to btl>+ controls, quantified in (f) from three independent replicates times three whole larvae each and normalized to Tubulin (Tub) or Akt levels. Akt and Tubulin were used as loading controls. g Ectopic expression of Dilp2 rescues the btl-knockdown size phenotype. Ubiquitous weak knockdown of btl using armadillo-GAL4 (arm>btl-RNAi) leads to small pupae (left). Co-expressing Dilp2 rescues this size phenotype (right), while having no significant effect on control animals (middle). Values are percent change in pupal size versus arm>+ controls. Statistics: one-way ANOVA with Dunnett's test for multiplecomparisons and Student's t-test for pairwise comparisons. *P<0.05, **P<0.01, ***P<0.001, compared to the control.
indicates reduced ecdysone-induced growth restriction (Fig. S3B) . Thus, the reduced body size observed with btl knockdown animals is mediated by effects in the tracheal system that lead to altered expression and reduced secretion of DILP2, -3, and -5 from the IPCs, resulting ultimately in reduced insulin-driven systemic growth.
Breathless knockdown leads to reduced tracheal growth and tissue hypoxia
In the tracheae, Btl acts to increase growth towards tissues experiencing hypoxia, because these tissues the FGF-like ligand Bnl. Thus, knockdown of btl would be expected to lead to reduced tracheal branching and oxygen supply to internal tissues. To confirm this, we observed tracheae associated with the fat body and quantified the number of branches and the total length of tracheal tube 51 . The tracheae of control animals display extensive terminal branches, whereas tracheae of btl>btl-RNAi animals exhibit significantly fewer of these fine processes (Fig. 4A) . Furthermore, the total length of the fat-body tracheal branch was greatly reduced in animals with reduced expression of btl in the trachea (Fig. 4B) , suggesting reduced oxygen supply leading to tissue hypoxia. To investigate this possibility, we examined the expression of bnl, which is upregulated in response to hypoxia to drive tracheal outgrowth towards oxygen-demanding tissues 33 . Loss of btl in the trachea led to strong bnl upregulation (Fig. 4C ), indicating that internal tissues were indeed experiencing hypoxia. We rationalized therefore that these animals would be sensitized to low-oxygen conditions. To test this, we reared control and animals with knockdown of btl in the trachea under hypoxic conditions (5% O2, vs. the normal 21% atmospheric level) and measured their survival to the pupal stage. Most control animals survived this environment, reflecting their ability to adapt to reduced oxygen levels, whereas none of the btl-RNAi animals survived to pupariation (Fig. 4D ), presumably dying from hypoxia-induced damage. Taken together, our data suggest that the insulinergic changes described above operate downstream of tissue hypoxia to adapt growth to oxygen availability.
To investigate whether the tracheae themselves were under the control of insulin, we assessed the effects of altering insulin signaling in this tissue. Although overexpression of Dilp2 rescued body growth of arm>btl-RNAi animals ( Fig. 3G) , it did not restore the growth of their tracheae ( Fig.   S3C ). Furthermore, tracheal knockdown of InR or Akt had no effect on systemic growth or pupal size, whereas loss of TOR signaling in the tracheae caused a strong reduction in body size ( Fig.   S3D ). Thus, our findings suggest that insulin works downstream of the growth of the tracheal system and oxygen levels, mediating their effects on systemic growth, and that the growth of tracheae themselves is insulin-independent.
Fig. 4.
Airway branching is reduced in animals with knockdown of breathless. a-b Knockdown of breathless (btl) in tracheae leads to a reduction in branching (right) of the terminal tracheal cells of the fat body branch compared to the btl>+ control (btl> crossed to wild type, w 1118 ). Representative images (a) and quantification (b) of the fat-body branch of larval tracheal terminal cells are shown. Scale bar, 50 µm. PB, primary branch; SB, secondary branch; TB, tertiary branch. c Whole boyd transcript levels of branchless (bnl), encoding the hypoxia-inducible FGF ligand of Btl, is strongly upregulated in larvae with trachea-specific btl knockdown, suggesting that tissues are experiencing hypoxia in these animals. d Loss of btl renders animals unable to survive in a low-oxygen environment (5% O2 levels), while most btl>+ controls develop to pupariation. Statistics: Student's t-test for pairwise comparisons. *P<0.05, ***P<0.001, compared to the control.
Environmentally or genetically induced hypoxic states mimics loss of breathless
The data above indicate that ubiquitous or trachea-specific loss of btl induces internal tissue hypoxia, which via reduced insulin leads to slow growth of the entire organism. To confirm that hypoxia per se is the cause of this growth inhibition, and to assess whether this inhibition is part of an adaptive response to hypoxia or a pathological result of low physiological oxygen levels, we investigated the effects of environmentally imposed hypoxia on larval growth. Wild-type (w 1118 )
animals reared under hypoxia (5% O2) displayed reduced pupal size, despite a developmental delay of pupariation extending the larval growth period, indicating strong growth inhibition phenocopying that seen with btl>btl-RNAi (Fig. 5A , 5B, and S4A).
The signaling pathway that detects low oxygen levels and triggers cellular adaptation programs is conserved between Drosophila and mammals. The main effector protein of this pathway is the transcription factor HIF-1a, encoded in Drosophila by the gene similar (sima) 52, 53 .
Under normoxic conditions, this protein is marked for proteasomal degradation through the oxygendependent activity of HIF-1a prolyl hydroxylase (Hph), also called Fatiga (Fga) in Drosophila [54] [55] [56] .
To differentiate between hypoxia-induced damage versus a genetic adaptive response, we activated the hypoxia-adaptation program by mutation of Hph, thus de-repressing HIF-1a-dependent downstream effects under normoxic conditions. Similar to hypoxic conditions or loss of btl function, lack of Hph resulted in growth inhibition and developmental delay despite the animals' normoxic environment (Fig. 5A , 5B, and S4A). This confirms that the oxygen-dependent growth effect is under genetic control, rather than arising from a lack of energy due to insufficient aerobic respiration or other pathological damage.
To evaluate whether the specific insulin-related phenotypes seen in btl-knockdown animals are components of the genetic hypoxia-adaptation program, we measured Dilp expression and DILP retention within the IPCs in hypoxic wild-type (w 1118 ) animals and in normoxic Hph mutants experiencing "genetic hypoxia". Like knockdown of btl, both manipulations led to strongly reduced Dilp3 and Dilp5 expression compared to normoxic controls (Fig. 5C ). Furthermore, IPC DILP2 and DILP5 levels were increased in hypoxic and Hph-mutant animals, indicating that insulin is retained in IPCs (Fig. 5D ). The lower effect on DILP3 levels possibly reflects the reduced expression of Dilp3 (a decrease of up to ~90%; Fig. 5C ), which indicates that the observed DILP3 level may in fact represent retention of this DILP as well.
Consistent with decreased systemic insulin signaling, both the low-O2 environment and genetic "hypoxia" caused by lack of Hph led to reduced pAkt levels ( Fig. 5F ). To further investigate
Fig. 5.
Hypoxia and genetic defects that mimic this condition inhibit growth and insulin secretion. a-b Quantification of pupal size (a) and representative images (b) of animals exposed to hypoxia (5% O2) or mutation of HIF-1a prolyl-hydroxylase (Hph), which genetically mimics hypoxia (even under normoxia conditions, 21% O2) compared to controls (w 1118 in normoxia). Values are percent change in pupal size versus w 1118 in normoxia controls. c-d Transcript levels of Dilp genes in whole animals (c) and DILP peptide levels (d) in the IPCs of animals exposed to hypoxia and Hph mutants compared to normoxic controls. Representative images of DILP2, -3, and -5 immunostainings in the insulin-producing cells (IPCs) are shown below. e Immunoblotting shows that levels of phosphorylated Akt (pAkt) is reduced under hypoxia and in Hph mutants compared to btl>+ controls, quantified in (f) from three independent replicates times three larvae each and normalized to Tubulin (Tub) or total Akt levels. Akt and Tubulin were used as loading controls. g A transgenic tGPH reporter of insulin signaling confirms that hypoxia reduces systemic insulin signaling in peripheral tissues, represented here by the fat body. Under conditions of normal insulin activity such as normoxia (left), the tGPH sensor is localized to the plasma membrane, while under conditions of low signaling, such as hypoxia, the sensor becomes primarily cytoplasmic. Scale bar, 20 µm. Statistics: one-way ANOVA with Dunnett's multiple-comparisons test. *P<0.05, **P<0.01, ***P<0.001, compared to the control. this, we made use of an in-vivo insulin-pathway reporter that reflects intracellular insulin-pathway activity based on plasma-membrane localization of GFP 47 . Under normoxic conditions, GFP fluorescence was localized to the membrane of fat-body cells, indicating high levels of insulinpathway activity, while under external hypoxia, the reporter remained cytoplasmic, confirming a reduction in insulin signaling (Fig. 5G) . Thus, tissue hypoxia, arising from tracheation defects or low external O2 levels, leads to the activation of growth-limiting mechanisms downstream of the HIF-1a oxygen-sensing pathway. Activation of this pathway naturally or by genetic manipulation leads to reduced insulin expression and release, reducing systemic insulin signaling and growth.
Like animals with btl knockdown, hypoxic wild-types and normoxic Hph mutants exhibited reduced ecdysone signaling (measured as expression of E75B) and upregulation of bnl ( Fig. S4B and S4C), consistent with an underlying defect common to all three manipulations -namely, the activation of the genetic hypoxia-adaptation program.
Loss of btl and reduced O2 levels cause adipose tissue hypoxia
The fat body is reported to secrete factors into the hemolymph that modulate insulin expression and release from the IPCs [11] [12] [13] 15, 16, 57 . To investigate whether this tissue also is involved in the insulinostatic hypoxia-adaptation response, we measured fat-body expression of bnl to determine whether this tissue experiences hypoxia under btl knockdown in the tracheae. Fat-body bnl expression was indeed elevated in these animals, indicating that this tissue experiences hypoxia when Btl-mediated tracheal growth is reduced (Fig. 6A) . To confirm the hypoxic state of the fat tissue, we made use of a genetic hypoxia reporter based on a GFP fusion with the oxygendependent degradation (ODD) domain of HIF-1a 58 . Under normoxic conditions, GFP::ODD is ubiquitinylated through the activity of Hph, targeting it for degradation. RFP expressed from the same regulatory sequences, but lacking the ODD, acts as a ratiometric control. In the fat body, the ODD::GFP reporter was rapidly degraded under normoxia, leading to a low GFP:RFP ratio ( Fig. 6B and 6C). In contrast, an increased ratio of GFP to RFP was observed in animals reared under 5%
O2, indicating reduced oxygen-dependent degradation of the ODD-linked GFP. Together these data show that the fat body experiences biologically significant hypoxia under genetically or environmentally induced reduced-oxygen conditions. Interestingly, we also observed a dramatic change in the size and quantity of lipid storage droplets in the fat body under hypoxic conditions induced by loss of btl (Fig. S5 ). The fat body is known to release large amounts of lipids under certain conditions. Although the known humoral factors from the fat that affect IPC physiology are peptides and proteins, other classes of signal molecules such as lipids may also be released from the fat under hypoxia to affect insulin secretion.
A fat-body-derived inhibitory signal represses insulin secretion under hypoxia
We next asked whether the brain and the IPCs alone could sense hypoxia and induce changes in insulin physiology, or whether the fat body might be necessary for organismal growth adaptation to hypoxia. To investigate this, we cultured larval brains (containing IPCs) alone or with fat bodies for 16 hours ex vivo under normoxic and hypoxic conditions and determined the effects of these manipulations on insulin expression and secretion (Fig. 6D) . While intact hypoxic larvae reduce Dilp3 and -5 expression (Fig. 5C ), we observed no decrease in expression of the three insulin genes in brains cultured alone under hypoxia compared to normoxia (Fig. 6E ). On the other hand, brains co-cultured with fat bodies under hypoxia displayed reduced Dilp expression compared to normoxic co-cultures. Together these observations demonstrate that the brain alone is insufficient for the hypoxia-adaptation response, and that a humoral signal from the fat body is required to downregulate Dilp3 and -5 expression To confirm these results in whole animals, we blocked the genetic hypoxia-response program in the fat body by expressing fat-body-specific RNAi against sima/HIF-1a. In these animals, even when grown under hypoxic conditions, the fat body should behave as if it is normoxic, allowing the contribution of the fat body to organismal responses to be isolated. Animals with fat-body knockdown of sima/HIF-1a also fail to downregulate Dilp transcription under hypoxia (Fig. 6F ). This suggests that Sima/HIF-1a activation in the fat tissue under hypoxic conditions is necessary for the repression of Dilp expression in the brain.
Furthermore, knockdown of sima/HIF-1a in the fat body also blocked the ability of hypoxic animals to repress insulin secretion (Fig. 6G) , indicating that activation of HIF-1a is required in the fat body for the hypoxia-adaptation program that modulates IPC insulin secretion.
To confirm the requirement for the presence of the fat body for DILP2 retention under hypoxia, we cultured wild-type brains either alone or with wild-type or Hph-mutant fat bodies, under normoxia and hypoxia. DILP2 was retained when brains were co-cultured with wild-type fatbody tissue under hypoxia, but not in brains cultured alone under these conditions (Fig. 6H) , indicating again that one or more signals secreted from the fat tissue is required to induce the insulin-retention under hypoxia. To assess the genetic control of this signal, we co-cultured wildtype brains with Hph-mutant fat bodies under normoxia. We found that DILP2 was retained in the IPCs, similar to the effect seen in hypoxic co-culture experiments. Taken together these results demonstrate that the activity of the HIF-1a hypoxia-adaptation program within the fat body is the determinant of IPC insulin retention. brains with wild-type fat body causes DILP2 retention under hypoxia (left). Brains incubated alone without fat body are unable to induce DILP2 retention under hypoxia (middle). Co-culture of wildtype brains with Hph-mutant fat bodies (with activated hypoxia-adaptation program) induces DILP2 retention under normoxia (right) and mimics that seen in true hypoxia (5% O2 levels), indicating that the fat-body-derived factor(s) is regulated by the Sima/HIF-1a hypoxia pathway. Representative images of DILP2 immunostainings in the IPCs are shown below. Statistics: Student's t-test for pairwise comparisons. *P<0.05, **P<0.01, ***P<0.001, compared to the control.
Of the known fat-body derived factors, Eiger is the only one that is reported to be insulinostatic, although its specific effects do not exactly match those we observed under hypoxia 16 . In any case, we sought to identify any contribution of Eiger to hypoxia-induced growth reduction by expressing RNAi against it in the fat body or against its receptor, Grindelwald, in the IPCs. We rationalized that if Eiger is involved, knockdown of Eiger and Grindelwald should provide rescue of the growth reduction observed in animals under hypoxic conditions. However, we found that neither Eiger nor Grindelwald rescued the body-size reduction, suggesting that they do not play a role in hypoxia-induced growth restriction (Fig. S6) . We also assessed other fat-body-derived factors, CCHamide-2, Stunted, and Growth-Blocking Peptides 1 and 2, although these are reported to be growth-promoting factors, to rule out their involvement. None of these factors appear to affect hypoxia-induced growth retardation. Thus, the insulinostatic factor released by the fat body appears to be a previously uncharacterized signal that acts inhibitorily on insulin secretion.
Discussion Central fat-tissue oxygen sensing remotely controls insulin secretion via inter-organ communication
In multicellular organisms, oxygen is essential for development and growth. For organisms to adapt their growth and development to oxygen availability, they must have the ability to sense changes in oxygen levels in their environment and to respond by adjusting their growth accordingly. Exposure to hypoxia limits growth during post-embryonic development in most animal species 27, 28, 59 . This appears to be an adaptive response rather than a simple passive effect of insufficient aerobic respiration, since the oxygen levels that reduce growth in many cases are above those that limit cellular metabolism 27, 28 . In this report, we identify one tissue in particular, the fat tissue, that detects internal oxygen levels and is important for inducing the growth-limiting effects of hypoxia. Our data show that, as an adaptive response to oxygen limitation, the fat tissue releases into the circulation one or more humoral factors that inhibit the expression and secretion of insulin from the brain to reduce systemic growth (Fig. 7) .
Fig. 7:
Proposed model for hypoxia sensing and insulin regulation. Tracheation of the fat body is regulated by the FGF ligand Branchless secreted from this tissue in response to local tissue hypoxia, triggering tracheal outgrowth via the FGF receptor Breathless. When the tracheal system is unable to deliver sufficient oxygen because of environmental oxygen levels or body growth, Hph is unable to trigger the degradation of Sima/HIF-1a, which induces the expression or release of one or more humoral factors from the fat tissue that act on the insulin-producing cells (IPCs) to down-regulate Dilp transcription and to block DILP release. Hypoxia thereby reduces circulating insulin through activation of a central oxygen sensor in the fat tissue, which slows the growth of the whole organism. During these low-oxygen conditions, activation of Branchless promotes insulinindependent growth of the tracheal airway tubes to increase oxygen supply to internal tissues. This system allows the organism to adapt its metabolism and growth to limited-oxygen conditions by reducing overall body growth through downregulation of insulin signaling while at the same time promoting development of the tracheal system to maintain oxygen homeostasis.
Oxygen homeostasis also requires the coordination of growth between the tissues that deliver oxygen and those that consume it. The development of the oxygen-delivery system is therefore oxygen-sensitive in both mammals and Drosophila. In mammals, local tissue hypoxia promotes angiogenesis via induction of many pro-angiogenic factors, including FGF 60 . In Drosophila, tissue hypoxia induces expression of the FGF-like ligand bnl, leading to branching of the tracheal airway tubes towards oxygen-depleted areas to promote survival by increasing oxygen delivery 33, 61 . Our study shows that this hypoxia-induced fat body mechanism operates downstream of insulin, since reduced insulin signaling in the trachea has no effect of overall body growth. This system therefore allows an adaptive response to low oxygen by reducing overall body-growth via suppression insulin signaling, while promoting hypoxia-induced FGF-dependent tracheal growth to increase oxygen supply to internal tissues.
Does oxygen transport determine insect size?
Most developing organisms stop growing after reaching a genetically predetermined size that is characteristic for the species. Much of the recent insight into the mechanisms that regulate body size has come from genetic studies in Drosophila showing that nutrition regulates body size via signals from the fat body 2, 7, [14] [15] [16] 62 . Although this helps explain how organisms modulate their growth and size according to nutritional conditions, the size-sensing mechanism that allows organisms to assess their size and stop their growth when they have reached optimal size has remained elusive.
However, recent evidence suggests that body size in insects may be determined by a mechanism that involves oxygen sensing 4 , and oxygen availability is known to place limits on insect body size 20, [22] [23] [24] . According to this recent insight, the limited growth ability of the tracheal system during development may limit overall body size due to downstream oxygen sensing 4 . The size of the tracheal system is established at the beginning of each developmental stage and remains largely fixed, aside from terminal branching, as the body grows until it eventually reaches the limit of the system's ability to deliver oxygen. This allows the body to "assess" its size by sensing internal oxygen concentrations and to terminate growth at a characteristic size that is determined by the size of the tracheal system. Our RNAi screen of the secretome and receptome suggests that the FGF receptor Btl, which is a key factor essential for tracheal growth during development, is a main determinant of body size. Limiting the growth of the tracheal system via loss of btl reduces overall growth and body size. Our data therefore support the notion that the tracheal system is part of a size-sensing mechanism that limits growth of the entire body and determines final body size.
Oxygen-dependent regulation of insulin gene expression via a fat-tissue signal(s)
Our results show that hypoxic conditions and loss of Hph activity selectively repress Dilp3 and The transcriptional response could also conceivably be a result of autocrine feedback regulation that regulates insulin in both Drosophila and mammals 63, 64 . However, lower secretion of DILPs, as we observe under hypoxic conditions, is generally associated with increased expression of Dilp3 and -5, which suggests that the hypoxia-induced repression of Dilp3 and -5 is a specific transcriptional response and not a consequence of autocrine effects. Together our results indicate that part of oxygen-dependent growth regulation is mediated by transcriptional control of Dilp3 and -5. It will be important to identify in future studies the fat-tissue factor(s) involved and the mechanism by which insulin production is regulated.
Effects of tissue hypoxia in mammals
Cell and tissue hypoxia are also observed in human conditions of obesity and cancer. The insect fat body performs the functions of mammalian fat and liver tissues, serving as an endocrine organ that secretes factors that affect insulin signaling 11, 12, [14] [15] [16] 65 . Accordingly, perturbation of insulin signaling by adipose and hepatic tissue hypoxia is also observed in mammalian systems 66 . In mammals, obesity induces hypoxia within adipose tissue due to the rarefaction of vascularization of this tissue and the resulting low blood flow 67 . This leads to the production and release of inflammatory mediators and other adipokines that are associated with the pathophysiology of obesity-related metabolic disorders including diabetes [68] [69] [70] [71] [72] [73] . Although loss of normal -cell activity is considered a main factor in diabetes, the mechanism by which tissue hypoxia affects insulin secretion is poorly understood. Our finding of one or more hypoxia-induced fat-body-derived insulinostatic humoral factors opens new avenues for understanding the role of adipose-tissue hypoxia in obesity and its impact on diabetes.
Obesity also leads to physical and hormonal changes that affect breathing patterns, causing apnea and thus intermittent episodes of systemic hypoxia 74 . These hypoxic periods can induce changes in the liver, leading to fatty liver disease and dyslipidemia, which have their own insulinotropic effects. Furthermore, hypoxia-induced programs play important roles in tumor formation. During cancer development, tumor cells undergo a metabolic reprogramming, the socalled "Warburg effect," in which their metabolism shifts from oxidative phosphorylation to glycolysis 75 . Activation of HIF-1a is believed to play a key role in driving this shift. Because the hypoxia-sensing mechanism and the insulin-signaling system are conserved between flies and mammals, understanding the effects of hypoxia on the fat body could thus provide insight into many human disease states.
The identity of the oxygen-dependent adipokine(s) that inhibits insulin secretion
Our work shows that one or more insulinostatic factors relay information from the fat-body oxygen sensor to the IPCs about the amount of internal oxygen to adapt growth and metabolism to oxygen conditions. This raises the question of the identity and function of the humoral signal(s). Many of the known Drosophila adipokines that affect insulin secretion from the IPCs are regulated by nutrient-dependent TOR-pathway activity in the fat body, including CCHamide-2 12 , Eiger 16 , FIT 13 , GBP1 and GBP2 14 , and Stunted 15 . On the other hand, our data suggest that the humoral factor(s)
released by the fat under hypoxia is released in response to hypoxia-induced HIF-1a pathway activation. However, hypoxia is known to inhibit TOR pathway activity via Sima/HIF-1a activation of the TSC1/2 activator Scylla/REDD1 76, 77 , making it possible that the HIF-1a-dependent fat-body oxygen-sensing mechanism converges on the TOR-dependent nutrient-sensing mechanism. Since our ex-vivo organ-culture experiments demonstrate that the signal(s) released by the fat body under hypoxia is inhibitory, Eiger (orthologous to the pro-inflammatory cytokine TNF-alpha), which inhibits Dilp-gene expression, seems the most apt candidate among the known factors. However, hypoxia strongly induces DILP retention, while Eiger is reported to have no effect on this process, and Eiger does not affect Dilp3 expression 16 . Furthermore, fat-body RNAi against Eiger and knockdown of its receptor Grindelwald in the IPCs had no effect on hypoxia-induced growth inhibition. Thus, if Eiger is involved at all in mediating the effect of fat-body hypoxia on IPC activity, it likely acts in coordination with other adipokine factors.
In mammals, several adipokines regulate -cell function and insulin secretion, including leptin, which conveys information about fat storage and is a functional analog of the Drosophila fatderived cytokine Unpaired-2 11, 78 . Interestingly, we observed that hypoxia induced by btl knockdown caused strong increase in fat-body lipid-droplet size, indicating a change in lipid metabolism within the fat tissue. It is conceivable that the signal(s) released by the fat body in response to hypoxia is a lipid or a lipid-binding protein. For example, the mammalian Fatty Acid
Binding Protein 4 (FABP4) is an insulin-modulating adipokine that is influenced by obesogenic conditions that lead to adipose tissue hypoxia 79 , and orthologous proteins are encoded by the Drosophila genome. Although this shows that fatty-acid-binding proteins can regulate insulin secretion, FABP4 stimulates insulin secretion, while our data suggest that the adipokine relaying information between the fat-tissue oxygen sensor and the IPCs acts as an inhibitor of insulin secretion. Our study opens future avenues for uncovering inter-organ crosstalk mechanism that regulate insulin secretion in relation to conditions associated with hypoxia.
In conclusion, our study unravels a mechanism that allows organisms to adapt their metabolism and growth to environments with low oxygen. Hypoxia activates a fat-tissue oxygen sensor that remotely controls the secretion of insulin from the brain by inter-organ communication.
This involves the activation of a HIF-1a-dependent genetic hypoxia-adaptation program within the fat tissue, which then secretes one or more humoral signals that alter insulin-gene expression and repress insulin secretion, thereby slowing growth. Given the conservation of oxygen-sensing systems and the influence of oxygen on growth between Drosophila and mammals, a similar adaption response may operate in mammals via adipose tissue oxygen-sensing to maintain oxygen homeostasis.
Methods
Fly strains and husbandry
Animals were reared on standard cornmeal-yeast medium (Nutri-Fly, Bloomington recipe) at 25°
and 60% relative humidity, under a 12L:12D light cycle. The AkhR-GAL4::p65 transgene containing the enhanced activator GAL4::p65 80 drives very strongly in the larval fat body. The GAL4::p65 was "recombineered" into genomic BAC construct CH322-147J17 81 obtained from Children's Hospital Oakland Research Institute (Oakland, CA, US), replacing the first coding exon, and the construct was integrated into the attP2 genomic site by standard injection methods. The following stocks were obtained from the Bloomington Drosophila stock center: arm-GAL4 (#1560), 
RNAi screen for pupal size
A list of genes encoding the secretome (secreted proteins) and receptome (membrane-associated proteins) was generated using ENSEMBL and GLAD gene-ontology databases 87, 88 . UAS-RNAi lines against 1,845 genes for the screening of the secretome and receptome were obtained from the Bloomington Drosophila stock center 36 and the Vienna Drosophila Resource Center (VDRC) 35 , and transformant IDs are given in Table S1 . Males from each RNAi line were crossed to da-GAL4 virgin females, animals were allowed to lay eggs for 24 hours, and the average size of pupal offspring was determined from images acquired with a Point Grey Grasshopper3 camera using a custom MATLAB script (MATLAB R2016b, The MathWorks, Inc., Natick, Massachusetts, USA) 89 . Each line was given a Z-score, calculated as the number of SD between that line's average and the average of all lines. Lines with a Z-score between -2 and 2, corresponding in this data set roughly to a ±15% size abnormality, were not analyzed further, while 89 lines with greater effect were identified.
Tracheal measurements and hypoxic survival rates
To determine tracheal length and branching, L3 larvae 96 hours after egg lay (AEL) for control; 120 hours for btl-RNAi animals to account for slowed growth were heat-fixed in a drop of glycerol on a microscope slide on a 60 °C heat block until they became relaxed. Tracheal cells and branching of the fat-body terminal branches were visualized in whole larvae by imaging of tracheae labeled with GFP or by direct light microscopy. Length and branching were manually quantified using the FIJI (NIH) software package 34, 90 . To determine survival rates of btl knockdown animals, timed egg-lays were performed, and first-instar (L1) larvae were transferred to fly vials containing standard food and incubated in either hypoxia (5% O2) or normoxia (21% O2, normal atmospheric oxygen concentration), and the number of animals surviving to the pupal stage was determined. The low-oxygen environment was generated by slowly passing 5% O2, 95% N2 through a clear, airtight plastic chamber placed inside a 25 °C, 12L:12D incubator. Gas was bubbled through water upstream and downstream of the chamber, to provide humidity and to prevent infiltration of outside air, and vented outside the incubator. The chamber was flushed with high-flow-rate gas for 5 minutes after any opening.
Analysis of developmental timing and growth rates
To synchronize larvae for growth-rate and developmental-timing assays, flies were allowed to lay eggs for 4 hours on apple-juice agar plates supplemented with yeast paste. Newly hatched L1 larvae were transferred into vials with standard food (30 per vial to prevent crowding) 24 hours later. To determine growth rates, synchronized larvae were weighed at time points 75-96 hours AEL in groups of 5-10 animals. For developmental timing experiments, pupariation time was determined manually.
Ex-vivo organ co-culture
For organ co-culture experiments, brains and fat bodies were dissected from 96-hour-AEL wildtype w 1118 larvae or 120-hour-AEL Hph-mutant larvae (to adjust for their slow growth) in cold Schneider's culture medium (Sigma-Aldrich #S0146) containing 5% fetal bovine serum (Sigma).
Fifty brains, with or without fat bodies present, were incubated in 50 μl culture medium for 16
hours at 25 °C in small dishes in moist chambers in either hypoxia or normoxia. After incubation, brains were removed for immunostaining and qPCR analyses.
Expression analysis by qPCR
To quantify gene expression by quantitative real-time PCR (qPCR), mRNA was prepared from six sets of five whole larvae (96 hours AEL for btl>+ controls and normoxia animals, and 120 hours AEL for btl-RNAi larvae, animals raised under hypoxia, and Hph mutants to adjust for their slower growth) using the RNeasy Mini Kit (Qiagen #74106) with DNase treatment (Qiagen #79254). RNA yield was determined using a NanoDrop spectrophotometer (ThermoFisher Scientific), and cDNA was generated using the High-Capacity cDNA Reverse Transcription Kit with RNase Inhibitor (ThermoFisher #4368814). qPCR was performed using the QuantiTect SYBR Green PCR Kit (Fisher Scientific #204145) and an Mx3005P qPCR System (Agilent Technologies). Expression levels were normalized against RpL32. The primer pairs used are listed below.
bnl: TGCCCTATCACAGAGTTGC and ACCTACACGAACGCCATCAC
E75B: CAACAGCAACAACACCCAGA and CAGATCGGCACATGGCTTT
Dilp2: CTCAACGAGGTGCTGAGTATG and GAGTTATCCTCCTCCTCGAACT
Dilp3: CAACGCAATGACCAAGAGAAC and GCATCTGAACCGAACTATCACTC
Dilp5: ATGGACATGCTGAGGGTTG and GTGGTGAGATTCGGAGCTATC
InR: CTCAGCCATACCAGGGACTTT and CTCTCCATAACACCGCCATC
RpL32: AGTATCTGATGCCCAACATCG and CAATCTCCTTGCGCTTCTTG
Western-blotting analysis
To quantify signaling-pathway activity downstream of InR, the level of Akt phosphorylation (pAkt) was determined by Western blot. For hypoxia experiments, larvae were transferred to 5% O2 at 72 hours AEL and analyzed 24 hours later, compared with 96-hour-AEL normoxic controls. Hph mutant larvae were assayed at 120 hours AEL. For each sample, three larvae were homogenized in SDS loading buffer (Bio-Rad), boiled for five minutes, centrifuged at 14,000×g for five minutes to pellet debris, and electrophoresed through a precast a 4-20% polyacrylamide gradient gel (BioRad). Proteins were transferred to a PVDF membrane (Millipore), and the membrane was blocked washes in PBST, tissues were mounted in Vectashield (Vector Labs #H-1000) and imaged using a Zeiss LSM 800 confocal microscope and Zen software. Retained insulin levels were calculated using the FIJI software package.
Fat-body tGPH insulin-sensor, ODD::GFP oxygen-sensor, and lipid-droplet analysis
A GFP-pleckstrin homology domain fusion protein (GPH) under control of the ubiquitous β-Tubulin promoter (tGPH) was used as an in vivo indicator of intracellular insulin signal transduction in the fat body. Insulin signaling activity causes recruitment of the GPH protein to the plasma membrane 47 . Hypoxia was induced 72 hours AEL, and hypoxic animals were assayed for fat-body GFP localization 24 hours later together with age-matched 96 hour AEL normoxic controls. Fat bodies were dissected in cold Schneider's medium and immediately imaged. A GFP::ODD sensor line, made up of the oxygen-dependent degradation domain of Sima fused to GFP, expressed throughout the animal from the ubiquitin-69E promoter, was used to determine whether the fat body experiences biologically significant hypoxia under 5% oxygen conditions 58 . This reporter protein is degraded at a rate proportional to tissue oxygen levels. Unmodified RFP expressed from the same regulatory elements provides a ratiometric denominator. Larvae were reared under normoxia or hypoxia, and at 96 or 120 hours AEL, respectively, fat bodies were dissected in cold Schneider's medium and immediately imaged. Levels of GFP and RFP signals were integrated using the FIJI package, and the ratio between them was calculated. Lipid droplets were detected using label-free Coherent Anti-Stokes Raman Scattering (CARS) microscopy. Fat bodies were dissected in cold Schneider's culture medium and immediately imaged using a Leica TCS SP8 confocal microscope as described 92, 93 . Lipid droplet number and density were quantified using FIJI software.
RNAi mini-screen of fat-body factors and IPC receptors
R96A08-GAL4 targeting the IPCs was crossed to RNAi constructs against receptors, and the strong fat-body driver AkhR-GAL4::p65 described above was crossed to lines targeting secreted factors.
Newly hatched larvae from 4-hour egg lays were transferred at 24 hours AEL to standard food vials and incubated at 25 °C in normoxia or hypoxia (5% O2) until pupariation. Pupal size was measured and for each genotype, the ratio for each possible hypoxic and normoxic vial pair was computed to make up each data set. Experimental data were compared to data from controls expressing UASLuciferase-RNAi, except for the ΔGbp1,2 deletion line, which was normalized to w 1118 .
Statistical analyses
Statistical tests and P-values are given within each figure legend. Statistics were calculated using GraphPad PRISM Software, applying ANOVA and Dunnett's test for multiple-comparisons tests and two-tailed Student's t-tests for pair-wise comparisons. Error bars indicate standard error of the mean (SEM), and P-values are indicated as: *, P<0.05; **, P<0.01; and ***, P<0.001.
FIGURE S1
Fig. S1. a-b Gene-ontology (GO) analysis of hits from the RNAi whose knockdown is associated with increased (a) or decreased (b) pupal size.
FIGURE S2
Fig. S2. a Knockdown of breathless (btl) in the trachea (btl>btl-RNAi) with two additional RNAi lines from VDRC (transformant ID number 950 and 27108) targeting independent sequences of btl reduces pupal body size compared to the control (btl> crossed to wild type, w 1118 ). b Duration of larval development determined by the onset of pupariation of animals with trachea-specific btl knockdown compared btl>+ driver (btl> crossed to wild type, w 1118 ) and btl-RNAi/+ (btl-RNAi crossed to wild type, w 1118 ) controls. Statistics: one-way ANOVA with Dunnett's multiplecomparisons test. ***P<0.001, compared to the control.
FIGURE S3
Fig. S3. a Duration of larval development determined by the onset of pupariation of da>InR-RNAi animals with global knockdown of the insulin receptor (InR), and ppl>TSC1/2 animals with fatbody-specific TOR inhibition compared to controls (w 1118 ). b Transcript levels of the ecdysoneinducible E75B gene. c Effect of global btl knockdown and Dilp2 overexpression using the weak ubiquitous arm> driver on the number of thick terminal branches (TTBs) per terminal cell, quantified as the number of cell projections. d Pupal size changes in animals with trachea-specific loss of breathless (btl) (btl>btl-RNAi), insulin signal transduction (btl>InR-RNAi and btl>AKT-RNAi), or TOR signaling (btl>TSC1/2 and btl>TOR DN ) compared to btl>+ controls (btl> crossed to wild type, w 1118 ). Statistics: one-way ANOVA with Dunnett's test for multiple-comparisons and Student's t-test for pairwise comparisons. *P<0.05, **P<0.01, ***P<0.001, compared to the control. 
FIGURE S6
Fig. S6. Mini-screen of fat-body factors and receptors. To assess the contributions of known fatbody factors and IPC-expressed receptors to hypoxia-induced size reduction, we assayed RNAi lines and mutants for this effect, hypothesizing that knocking down a factor or receptor that is involved in the insulinostatic response would rescue the size reduction (i.e., lead to larger pupae) under hypoxia. AkhR-GAL4::p65 (fat body) and R96A08-GAL4 (IPCs) drove RNAi against secreted factors and receptors, respectively. Zero change indicates that an RNAi treatment had no hypoxiaspecific effect -the ratio between hypoxic and normoxic sizes was the same as for controls. Roughly +20% would represent a complete blockage of hypoxia-induced size reduction. CCHa2/CCha2-R results are inconsistent with each other, and a size increase upon CCHa2-R knockdown is inconsistent with its reported insulinotropic effects; thus perhaps the CCHa2-R-RNAi-#1 phenotype reflects off-target effects. Statistics: two-tailed Student's t-test for pairwise comparisons versus controls. ***P<0.001, compared to the Luciferase control.
